ArticleTaiwan journal of ophthalmology

One-year results of switching to aflibercept for persistent diabetic macular edema resistant to bevacizumab.

Mahmoud Alaa Abouhussein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.